ASTRAZENECA WORKING FAST TO COMPILE DATA TO APPLY FOR US APPROVAL FOR ITS COVID-19 VACCINE

Highlights

• AstraZeneca said that it was planning to apply for US approval in upcoming weeks but there has been a delay

• In a briefing following the release of first-quarter results, AstraZeneca Chief Executive Pascal Soriot said that there was nothing wrong with the data, but the dataset was very big

The United Kingdom-based drugmaker on Friday said that it working as fast as possible in order to comp....